Citadel Advisors LLC Invests $664,000 in GoHealth, Inc. (NASDAQ:GOCO)

Citadel Advisors LLC purchased a new stake in shares of GoHealth, Inc. (NASDAQ:GOCO - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 49,613 shares of the company's stock, valued at approximately $664,000. Citadel Advisors LLC owned approximately 0.22% of GoHealth at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Wells Fargo & Company MN lifted its holdings in shares of GoHealth by 28.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,760 shares of the company's stock worth $37,000 after buying an additional 607 shares in the last quarter. Bank of America Corp DE lifted its stake in GoHealth by 22.8% in the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company's stock worth $105,000 after purchasing an additional 1,452 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in GoHealth by 99.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company's stock valued at $79,000 after purchasing an additional 4,204 shares during the period. Barclays PLC grew its position in shares of GoHealth by 9.6% during the 4th quarter. Barclays PLC now owns 10,504 shares of the company's stock valued at $140,000 after purchasing an additional 924 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of GoHealth by 41,225.5% in the fourth quarter. Russell Investments Group Ltd. now owns 21,076 shares of the company's stock worth $282,000 after purchasing an additional 21,025 shares during the period. 24.21% of the stock is owned by institutional investors.

GoHealth Price Performance

Shares of NASDAQ:GOCO traded down $0.09 on Wednesday, hitting $5.86. The company's stock had a trading volume of 20,094 shares, compared to its average volume of 42,176. The company has a market capitalization of $139.10 million, a PE ratio of -1.67 and a beta of 1.71. The company has a debt-to-equity ratio of 1.72, a current ratio of 1.18 and a quick ratio of 1.18. The company has a 50-day simple moving average of $8.84 and a 200 day simple moving average of $12.35. GoHealth, Inc. has a 1 year low of $5.40 and a 1 year high of $21.00.

GoHealth (NASDAQ:GOCO - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.21). GoHealth had a negative net margin of 4.32% and a negative return on equity of 17.17%. The company had revenue of $220.97 million during the quarter, compared to analysts' expectations of $225.91 million. Sell-side analysts forecast that GoHealth, Inc. will post -5.5 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reissued a "sector perform" rating and set a $18.00 price objective on shares of GoHealth in a research note on Monday, May 19th.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.